Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a narrower glucose range improve diabetes control in children?

NCT ID NCT07376850

First seen Jan 31, 2026 · Last updated Jun 19, 2026 · Updated 23 times

Summary

This study will enroll 120 children and teens with Type 1 Diabetes who use automated insulin pumps. Half will aim for the standard blood sugar range (70-180 mg/dL), while the other half will target a tighter range (70-140 mg/dL). Over 12 months, researchers will compare blood sugar control, risk of lows, and emotional burden to see if the tighter target is better.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Medical University of Warsaw

    Warsaw, Poland

    Contact

  • Motol University Hospital

    Prague, Czechia

    Contact Email: •••••@•••••

  • Schneider Children's Medical Center of Israel

    Petah Tikva, Israel

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Structured diabetes education on Time in Normal Glycemia (TING) vs. Time in Range (TIR)

What this could lead to

If successful, this could show that a tighter glucose target is safe and effective for children with Type 1 Diabetes, potentially updating global treatment guidelines.

What could go wrong

This is a relatively small, early-stage study (120 participants) and the tighter target may increase the risk of low blood sugar or family stress without clear benefit.

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.